Bulls vs Bears updated 6/18/15
Bullish
- FDA Imetelstat hold removed on 11/3/14
- Janssen to initiate a
- Phase 2 study in patients with myelofibrosis in mid-2015,
- Followed by a Phase 2 study in patients with myelodysplastic syndromes at the end of 2015
Bearish
- Single candidate, Imetelstat has blemished history, clinical trial put on hold 3/12/14
- Mgmt sued for SEC misconduct
No comments:
Post a Comment